Banco J.P. Morgan S.A. is acting as exclusive financial advisor, Goodwin LLP as exclusive legal advisor, and PWC as exclusive accounting and tax advisor to Acino....
Acino’s Acquisition of M8 Pharmaceuticals
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
ImmunityBio’s $50.0 Million Offering
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
Wave Life Sciences’ Collaboration with GSK
Goodwin Procter advised Wave Life Sciences on the deal. Wave Life Sciences (Nasdaq: WVE) announced its strategic collaboration with GSK (LSE/NYSE: GSK) to advance oligonucleotide therapeutics, including...
SpringWorks Therapeutics’ $300 Million Shares Private Placement
Goodwin Procter advised SpringWorks Therapeutics on the deal. SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue...
Gandeeva’s $40 Million Series A Funding
Goodwin advised Gandeeva on the deal. Gandeeva announced its Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures,...